medigraphic.com
ISSN 2448-8909 (Print)

2005, Number 2

Next >>

Med Crit 2005; 19 (2)

Morbidity and mortality associated with HELLP syndrome in Yucatan

Salazar EDC, Negreros CA, Díaz CI, Garrido HEM

Language: Spanish
References: 17
Page: 45-49
PDF size: 61.83 Kb.


ABSTRACT

Introduction: HELLP syndrome is a multisystemic disease and may be associated with preeclampsia or eclampsia; its mortality is high.
Objective: To know the morbidity and mortality due to HELLP syndrome in Yucatan.
Design: Descriptive and multicentric study.
Setting: ICUs of three hospitals, Merida Yucatan; Mexico.
Patients: Forty patients (mean age 25 ± 7 yrs) with HELLP syndrome, during a 14-month period. Methods: It was used the 3-class system of classification (Mississippi). Clinical features, gestational age, resolution of pregnancy, laboratory findings and morbidity and maternal mortality was evaluated.
Results: Of the total of 40 patients, 17 (42.5%), 18 (45%) and 5 (12.5%) corresponded to class I, II and III, respectively. Twenty (50%) patients suffered preeclampsia and 12 (30%) eclampsia; in the rest of patients was not detected hypertensive disease associated to pregnancy. Nine (22.5%) patients developed acute renal failure. The mortality rate was 7.5%.
Conclusions: In this study, HELLP syndrome was associated to a low mortality rate.


REFERENCES

  1. Geary M. The HELLP syndrome. Br J Obstet Gynecol 1997;104:887-91.

  2. Saphier C. Hemolysis, elevated liver enzymes, and low platelets (HELLP) syndrome: A review of diagnosis and management. Semin Perinatol 1998;22:118-133.

  3. Rojas PG, Viveros RE, Kambly AA. Síndrome de HELLP. Estado crítico. Conceptos actuales. Ginecol Obstet Mex 1996;64:64-72.

  4. Sibaí BM, Ramadan MK, Ustan I, Salama M, Mercer BM, Friedman SA. Maternal morbidity and mortality in 442 pregnancies with hemolysis, elevated liver enzymes, and low platelets (HELLP syndrome). Am J Obstet Gynecol 1993;169:1000-6.

  5. O’Hara PM. HELLP syndrome: Recognition and perinatal management. Am Fam Physician 1999;160:829-39.

  6. Velasco MV, Navarrete HE, Cardona PJ, Madrazo NM. Mortalidad materna por preeclampsia-eclampsia en el Instituto Mexicano del Seguro Social 1987-1996. Rev Med IMSS (Mex) 1997;35(6):451-6.

  7. Rojas PG, Viveros RE, Fernández CE, Esparza JJ, Cabra ZR, Kambly AA. Síndrome de HELLP. Consecuencias severas de la enfermedad hipertensiva inducida por el embarazo. Ginecol Obstet Mex 1996;64:523-7.

  8. Argueta ZM, Neir MC, Lira PJ, Ibarguengoitia F, Vazquez JM. Síndrome de HELLP. Experiencias de 7 años en el Instituto Nacional de Perinatología. Ginecol Obstet Mex 1995;63:217-21.

  9. Romero AJ, Lara GA, Ramos LJ, Izquierdo PJ. Morbimortalidad materna en el síndrome de HELLP. Ginec Obstet Mex 2001;69:189-93.

  10. Sibai BM, Ramaden MK, Radha SCh, Friedman SA. Pregnancies complicated by HELLP syndrome (hemolysis, elevated liver enzymes and low platelets): subsequent pregnancy outcome and long-term prognosis. Am J Obstet Gynecol 1995;172:125-9.

  11. Helguera MA, Tenorio MR, Vigil DP, Gracia CE. Síndrome de HELLP. Análisis de 102 casos. Ginec Obst Mex 1996;64: 528-30.

  12. Dreyfus M, Tissier I, Baldaut JJ, Ritter J. HELLP syndrome. Review and update. J Gynecol Obstet Biol Reprod 1997;26(1):9-15.

  13. Devyani S. Maternal and neonatal outcome of pregnancies complicated with maternal HELLP syndrome. J Perinatol 1997;17:266-269.

  14. Isler C. Maternal mortality associated with HELLP syndrome. Am J Obstet Gynecol 1999;181:924-928.

  15. Magann E. Twelve steps to Optimal Management of HELLP Syndrome. Clin Obstet Gynecol 1999;42:532-550.

  16. Martin J. Analysis of 454 pregnancies with severe preeclampsia/eclampsia HELLP syndrome using the 3-class system of classification. Am J Obstet Gynecol 1993;68:386.

  17. Audibert F. Clinical utility of strict diagnostic criteria for the HELLP syndrome. Am J Obstet Gynecol 1996;175:460-464.




2020     |     www.medigraphic.com